|
Status |
Public on Apr 30, 2011 |
Title |
SCGB3A2 suppresses bleomycin-induced pulmonary fibrosis through activation of STAT1 and up-regulation of SMAD7  |
Organism |
Mus musculus |
Experiment type |
Expression profiling by array
|
Summary |
We report for the first time that secretoglobin (SCGB) 3A2, a novel cytokine-like molecule, predominantly expressed in pulmonary airways epithelium, drastically reduced the severity of lung fibrosis using bleomycin-induced mouse model.
|
|
|
Overall design |
DNA microarrays were performed using RNAs isolated from mouse lungs in two experiments. In the first experiments, mice were adminitered intravenously SCGB3A2 or PBS once daily for a week, starting on day 14 after BLM administration, and in the second experiments, SCGB3A2 or PBS was administered intravenously for 12 hrs.
|
|
|
Contributor(s) |
Kimura S, Kurotani R |
Citation(s) |
21478551 |
|
Submission date |
Apr 28, 2010 |
Last update date |
May 25, 2012 |
Contact name |
Reiko Kurotani |
E-mail(s) |
[email protected]
|
Phone |
+81-45-787-2575
|
Fax |
+81-45-788-1470
|
URL |
http://www.yokohama-cu.ac.jp/
|
Organization name |
Yokohama City University School of Medicine
|
Lab |
Cardiovascular Research Institute
|
Street address |
3-9,fukuura,kanazawa-ku
|
City |
Yokohama |
State/province |
Kanagawa |
ZIP/Postal code |
236-0004 |
Country |
Japan |
|
|
Platforms (1) |
|
Samples (16)
|
|
Relations |
BioProject |
PRJNA126181 |